338
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxicity and in vitro characterization studies of synthesized Jeffamine-cored PAMAM dendrimers

, , , &
Pages 127-136 | Received 19 Dec 2012, Accepted 10 Jun 2013, Published online: 18 Jul 2013

References

  • Agashe HB, Dutta T, Garg M, Jain NK. Investigations on the toxicological profile of functionalized fifth-generation poly(propylene imine) dendrimer. J pharm pharmacol, 2006;58:1491–8
  • Beezer AE, King ASH, Martin IK, Mitchell JC, Twyman LJ, Wain CF. Dendrimers as potential drug carriers; Encapsulation of acidic hydrophobes within water soluble PAMAM derivatives. Tetrahedron, 2003;59:3873–80
  • Chen HT, Neerman MF, Parrish AR, Simanek EE. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc, 2004;126:10044–8
  • Cheng YY, Xu TW. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Eur J Med Chem, 2005;40:1188–92
  • D'emanuele A, Attwood D. Dendrimer--drug interactions. Adv Drug Delivery Rev, 2005;57:2147–62
  • D'souza SS, Deluca PP. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res, 2006;23:460–74
  • El-Sayed M, Ginski M, Rhodes C, Ghandehari H. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release, 2002;81:355–65
  • Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today, 2001;6:427–36
  • Felt O, Buri P, Gurny R. Chitosan: A unique polysaccharide for drug delivery. Drug Dev Ind Pharm, 1998;24:979–93
  • Fischer D, Bieber T, Li YX, Elsasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res, 1999;16:1273–9
  • Fischer D, Li YX, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials, 2003;24:1121–31
  • Goldberg DS, Vijayalakshmi N, Swaan PW, Ghandehari H. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. J Control Release, 2011;150:318–25
  • Hong SP, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, Orr BG, Baker JR, Holl MMB. Interaction of polycationic polymers with supported lipid bilayers and cells: Nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chem, 2006;17:728–34
  • Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem, 2007;18:2054–60
  • Kolhe P, Misra E, Kannan RM, Kannan S, Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm, 2003;259:143–60
  • Lee JH, Lim YB, Choi JS, Lee Y, Kim TI, Kim HJ, Yoon JK, Kim K, Park JS. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconjugate Chem, 2003;14:1214–21
  • Lin YL, Fujimori T, Kawaguchi N, Tsujimoto Y, Nishimi M, Dong ZQ, Katsumi H, Sakane T, Yamamoto A. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats. J Control Release, 2011;149:21–8
  • Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled polyamidoamine dendrimers in vivo (vol 65, pg 133, 2000). J Control Release, 2000;68:299–302
  • Mathot F, Van Beijsterveldt L, Preat V, Brewster M, Arien A. Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J Control Release, 2006;111:47–55
  • Mitchell SA, Reynolds TD, Dasbach TP. A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose. Int J Pharm, 2003;250:3–11
  • Morgan MT, Nakanishi Y, Kroll DJ, Griset AP, Carnahan MA, Wathier M, Oberlies NH, Manikumar G, Wani MC, Grinstaff MW. Dendrimer-encapsulated camptothecins: Increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Res, 2006;66:11913–21
  • Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm, 2008;34:1394–405
  • Mura P, Faucci MT, Bettinetti GP. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin. Eur J Pharm Sci, 2001;13:187–94
  • Najlah M, Freeman S, Attwood D, D'emanuele A. In vitro evaluation of dendrimer prodrugs for oral drug delivery. Int J Pharm, 2007;336:183–90
  • Newkome GR, Nayak A, Behera RK, Moorefield CN, Baker GR. Chemistry of micelles series. 22. cascade polymers – Synthesis and characterization of 4-directional spherical dendritic macromolecules based on adamantane. J Org Chem, 1992;57:358–62
  • Nokhodchi A, Maghsoodi M. Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique. Aaps Pharmscitech, 2008;9:54–9
  • Patri AK, Kukowska-Latallo JF, Baker JR. Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Delivery Rev, 2005;57:2203–14
  • Percec V, Ahn CH, Barboiu B. Self-encapsulation, acceleration and control in the radical polymerization of monodendritic monomers via self-assembly. J Am Chem Soc, 1997;119:12978–9
  • Perumal OP, Inapagolla R, Kannan S, Kannan RM. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials, 2008;29:3469–76
  • Sadekar S, Ghandehari H. Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery. Adv Drug Delivery Rev, 2012;64:571–88
  • Sajeesh S, Sharma CP. Cyclodextrin--insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm, 2006;325:147–54
  • Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery -- A review. Pharm Sci Technol Today, 2000;3:138–45
  • Schluter AD. Dendrimers with polymeric core: Towards nanocylinders. Dendrimers, 1998;197:165–91
  • Svenson S, Chauhan AS. Dendrimers for enhanced drug solubilization. Nanomedicine (Lond), 2008;3:679–702
  • Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. A new class of polymers – Starburst-dendritic macromolecules. Polym J, 1985;17:117–32
  • Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. Dendritic macromolecules – Synthesis of starburst dendrimers. Macromolecules, 1986;19:2466–8
  • Tsai HC, Imae T. Fabrication of dendrimers toward biological application. Nanoparticles in Translational Science and Medicine, Prog Mol Biol Transl Sci, 2011;104:101–40
  • Tulu M, Aghatabay NM, Senel M, Dizman C, Parali T, Dulger B. Synthesis, characterization and antimicrobial activity of water soluble dendritic macromolecules. Eur J Med Chem, 2009;44:1093–9
  • Wong AD, Dewit MA, Gillies ER. Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers. Adv Drug Delivery Rev, 2012;64:1031–45

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.